157 related articles for article (PubMed ID: 22633179)
21. Crimean-Congo hemorrhagic fever in Europe: current situation calls for preparedness.
Maltezou HC; Andonova L; Andraghetti R; Bouloy M; Ergonul O; Jongejan F; Kalvatchev N; Nichol S; Niedrig M; Platonov A; Thomson G; Leitmeyer K; Zeller H
Euro Surveill; 2010 Mar; 15(10):19504. PubMed ID: 20403306
[TBL] [Abstract][Full Text] [Related]
22. Treatment of Crimean-Congo hemorrhagic fever.
Ergonul O
Antiviral Res; 2008 Apr; 78(1):125-31. PubMed ID: 18096251
[TBL] [Abstract][Full Text] [Related]
23. Crimean-Congo hemorrhagic fever among health care workers in Iran: a seroprevalence study in two endemic regions.
Mardani M; Rahnavardi M; Rajaeinejad M; Naini KH; Chinikar S; Pourmalek F; Rostami M; Shahri MH
Am J Trop Med Hyg; 2007 Mar; 76(3):443-5. PubMed ID: 17360865
[TBL] [Abstract][Full Text] [Related]
24. Epidemiological and behavioral factors associated with Crimean-Congo hemorrhagic fever virus infections in humans.
Sargianou M; Papa A
Expert Rev Anti Infect Ther; 2013 Sep; 11(9):897-908. PubMed ID: 24053271
[TBL] [Abstract][Full Text] [Related]
25. The risk of transmission of Crimean-Congo hemorrhagic fever virus from human cases to first-degree relatives.
Izadi S; Salehi M; Holakouie-Naieni K; Chinikar S
Jpn J Infect Dis; 2008 Nov; 61(6):494-6. PubMed ID: 19050365
[TBL] [Abstract][Full Text] [Related]
26. Recent progress in molecular biology of Crimean-Congo hemorrhagic fever.
Morikawa S; Saijo M; Kurane I
Comp Immunol Microbiol Infect Dis; 2007 Sep; 30(5-6):375-89. PubMed ID: 17692916
[TBL] [Abstract][Full Text] [Related]
27. Crimean-Congo hemorrhagic fever in Albania, 2001.
Papa A; Bino S; Llagami A; Brahimaj B; Papadimitriou E; Pavlidou V; Velo E; Cahani G; Hajdini M; Pilaca A; Harxhi A; Antoniadis A
Eur J Clin Microbiol Infect Dis; 2002 Aug; 21(8):603-6. PubMed ID: 12226691
[TBL] [Abstract][Full Text] [Related]
28. Crimean Congo hemorrhagic fever: requires vigilance and not panic.
Bajpai S; Nadkar MY
J Assoc Physicians India; 2011 Mar; 59():164-7. PubMed ID: 21751625
[TBL] [Abstract][Full Text] [Related]
29. Cytokine levels in Crimean-Congo hemorrhagic fever.
Papa A; Bino S; Velo E; Harxhi A; Kota M; Antoniadis A
J Clin Virol; 2006 Aug; 36(4):272-6. PubMed ID: 16765637
[TBL] [Abstract][Full Text] [Related]
30. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever.
Cevik MA; Erbay A; Bodur H; Eren SS; Akinci E; Sener K; Ongürü P; Kubar A
Clin Infect Dis; 2007 Oct; 45(7):e96-100. PubMed ID: 17806044
[TBL] [Abstract][Full Text] [Related]
31. Crimean-Congo hemorrhagic fever: prevention and control limitations in a resource-poor country.
Smego RA; Sarwari AR; Siddiqui AR
Clin Infect Dis; 2004 Jun; 38(12):1731-5. PubMed ID: 15227619
[TBL] [Abstract][Full Text] [Related]
32. Suspected Crimean Congo Haemorrhagic Fever cases in Albania.
Papa A; Bino S; Papadimitriou E; Velo E; Dhimolea M; Antoniadis A
Scand J Infect Dis; 2008; 40(11-12):978-80. PubMed ID: 18609200
[TBL] [Abstract][Full Text] [Related]
33. Crimean-Congo haemorrhagic fever virus in Kazakhstan (1948-2013).
Nurmakhanov T; Sansyzbaev Y; Atshabar B; Deryabin P; Kazakov S; Zholshorinov A; Matzhanova A; Sadvakassova A; Saylaubekuly R; Kyraubaev K; Hay J; Atkinson B; Hewson R
Int J Infect Dis; 2015 Sep; 38():19-23. PubMed ID: 26183415
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of PCR and ELISA-IgM results in the laboratory diagnosis of Crimean-Congo haemorrhagic fever cases in 2008 in Turkey].
Uyar Y; Carhan A; Albayrak N; Altaş AB
Mikrobiyol Bul; 2010 Jan; 44(1):57-64. PubMed ID: 20455399
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy.
Ergönül O; Celikbaş A; Dokuzoguz B; Eren S; Baykam N; Esener H
Clin Infect Dis; 2004 Jul; 39(2):284-7. PubMed ID: 15307042
[TBL] [Abstract][Full Text] [Related]
36. Crimean-Congo hemorrhagic fever: risk for emergence of new endemic foci in Europe?
Maltezou HC; Papa A
Travel Med Infect Dis; 2010 May; 8(3):139-43. PubMed ID: 20541133
[TBL] [Abstract][Full Text] [Related]
37. Effect of oral ribavirin treatment on the viral load and disease progression in Crimean-Congo hemorrhagic fever.
Bodur H; Erbay A; Akıncı E; Öngürü P; Bayazıt N; Eren SS; Kubar A
Int J Infect Dis; 2011 Jan; 15(1):e44-7. PubMed ID: 21106428
[TBL] [Abstract][Full Text] [Related]
38. Contact tracing and serosurvey among healthcare workers exposed to Crimean-Congo haemorrhagic fever in Greece.
Maltezou HC; Maltezos E; Papa A
Scand J Infect Dis; 2009; 41(11-12):877-80. PubMed ID: 19922073
[TBL] [Abstract][Full Text] [Related]
39. [Two Crimean-Congo hemorrhagic fever cases without history of tick contact from Ankara region].
Kaya Kiliç E; Yilmaz U; Cesur S; Koçak Tufan Z; Kurtoğlu Y; Bulut C; Kinikli S; Irmak H; Demiröz AP
Mikrobiyol Bul; 2009 Oct; 43(4):677-81. PubMed ID: 20084924
[TBL] [Abstract][Full Text] [Related]
40. Crimean-Congo hemorrhagic fever.
Vorou R; Pierroutsakos IN; Maltezou HC
Curr Opin Infect Dis; 2007 Oct; 20(5):495-500. PubMed ID: 17762783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
